Gonadorelin Acetate vs Kisspeptin-10
Gonadorelin Acetate (GnRH analog) and Kisspeptin-10 (Neuropeptide hormone) are documented as co-studied in the PeptiDex library. This page puts the two entries side by side on class, molecular weight, half-life, origin, mechanism and studied research areas — every value taken from the entry it belongs to.
Why these two are co-studied
Cross-referenced for research context — not a usage or combination recommendation.
At a glance
| Attribute | Gonadorelin Acetate | Kisspeptin-10 |
|---|---|---|
| Compound class | GnRH analog | Neuropeptide hormone |
| Research category | Hormonal & Sexual Health | Hormonal & Sexual Health |
| Length (amino acids) | 10 amino acids | 10 amino acids |
| Molecular weight | ~1182 g/mol | ~1302 g/mol |
| Half-life | ~2-10 min (distribution); ~10-40 min (terminal) | ~4 minutes (IV bolus, human) |
| Origin | Gonadorelin is a synthetic form of the endogenous decapeptide gonadotropin-releasing hormone (GnRH, also called LHRH). Its acetate salt is used clinically in reproductive endocrinology. | Kisspeptin-10 is the C-terminal decapeptide of kisspeptin, a neuropeptide encoded by the KISS1 gene. Kisspeptins are endogenous ligands for the KISS1R (GPR54) receptor and are central regulators of reproductive endocrinology. |
“Not documented” means the PeptiDex entry records no value for that field. Nothing on this page is estimated, and no figure is carried over from one compound to the other.
How Gonadorelin Acetate works
Gonadorelin is structurally identical to native GnRH and binds GnRH receptors on pituitary gonadotrophs, stimulating secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). Because it is the native decapeptide with a short half-life, pulsatile administration mimics physiological GnRH release, whereas continuous exposure can downregulate the receptor. It is used diagnostically and to stimulate the hypothalamic-pituitary-gonadal axis.
How Kisspeptin-10 works
Kisspeptin-10 binds the G-protein-coupled receptor KISS1R (GPR54) on hypothalamic GnRH neurons, stimulating the release of gonadotropin-releasing hormone. Downstream, GnRH acts on the pituitary to promote secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), placing kisspeptin at the apex of the hypothalamic-pituitary-gonadal axis. Because it acts upstream of GnRH, it is studied as a physiological modulator of reproductive hormone release.
Mechanistic descriptions reflect published research-literature understanding and are quoted from each compound's own entry. Much peptide research is preclinical (in-vitro or animal-model); mechanism in humans may differ and is not established for many compounds.
Where each one appears in the literature
The research contexts each entry documents. Listing a research area is not a claim of efficacy or a therapeutic indication, and the two lists are not scored against each other.
Gonadorelin Acetate
Kisspeptin-10
What sets each apart
Gonadorelin Acetate
Gonadorelin is the native GnRH decapeptide with a short half-life, contrasting with triptorelin, a modified long-acting GnRH superagonist that produces sustained receptor downregulation.
Kisspeptin-10
Kisspeptin acts one step upstream of GnRH (stimulating GnRH neurons), whereas gonadorelin/triptorelin act directly on pituitary GnRH receptors and HCG/HMG act at the gonadal level.
Frequently asked questions
What is gonadorelin?
Gonadorelin is synthetic gonadotropin-releasing hormone (GnRH), a decapeptide identical to the native hypothalamic sequence. It agonizes the pituitary GnRH receptor to trigger release of LH and FSH, making it a core research tool for probing the HPG axis.
Why must gonadorelin be given in pulses?
The GnRH receptor responds to pulsatile stimulation but desensitizes under continuous exposure, which paradoxically suppresses LH/FSH. Research protocols therefore administer gonadorelin intermittently (often modeling ~90-120 minute pulses) to sustain a gonadotropin response rather than shut it down.
How does gonadorelin differ from triptorelin?
Gonadorelin is native GnRH with a very short half-life, so it behaves as a pulsatile stimulus. Triptorelin is a modified super-agonist (D-Trp at position 6) with far greater potency and duration, which after an initial flare causes sustained receptor desensitization and downstream suppression.
What is kisspeptin-10?
Kisspeptin-10 (Kp-10) is the C-terminal decapeptide fragment of the larger kisspeptin-54 protein, the product of the KISS1 gene. It acts on the KISS1R (GPR54) receptor on hypothalamic GnRH neurons and is studied as an upstream trigger of the hypothalamic-pituitary-gonadal (HPG) axis, stimulating GnRH and downstream LH/FSH release.
What is kisspeptin-10 studied for?
In research it is studied as a stimulator of endogenous GnRH secretion and LH pulsatility, and in models of hypothalamic amenorrhea, reproductive endocrinology, and fertility. It has also been investigated in studies of sexual arousal processing. It is a research compound and is not an approved drug for these uses.
What does kisspeptin-10's short half-life imply for research design?
Its plasma half-life after IV bolus is only about 4 minutes, so single doses produce brief effects. To sustain an LH response, research protocols use continuous IV infusion or repeated boluses timed to mimic pulsatile GnRH release, rather than one-off administration.
Answers are the ones published on each compound's own PeptiDex entry. They are educational summaries of research-literature context and are not medical advice.